Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism

Clinical trial NCT00732771 · COMPLETED

Trial details

NCT number: NCT00732771
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Hyperaldosteronism

Start date: 2008-06-01
Primary completion: 2009-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.